Variant report
Variant | esv3333283 |
---|---|
Chromosome Location | chr4:69866513-69868461 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXA1 | chr4:69868219-69869053 | HepG2 | liver: | n/a | n/a |
2 | FOXA1 | chr4:69868246-69868899 | HepG2 | liver: | n/a | n/a |
3 | MBD4 | chr4:69866511-69867149 | HepG2 | liver: | n/a | n/a |
4 | MYC | chr4:69866669-69866747 | K562 | blood: | n/a | n/a |
5 | POLR2A | chr4:69866577-69866849 | HepG2 | liver: | n/a | n/a |
6 | POLR2A | chr4:69866498-69867187 | HepG2 | liver: | n/a | n/a |
7 | POLR2A | chr4:69867314-69867535 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr4:69867651-69867880 | HepG2 | liver: | n/a | n/a |
9 | POLR2A | chr4:69867808-69867887 | HepG2 | liver: | n/a | n/a |
10 | RFX5 | chr4:69868133-69868162 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250277 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146247966 | chr4:69866524-69866525 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs530423456 | chr4:69866546-69866547 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs113081208 | chr4:69866551-69866552 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs548296898 | chr4:69866555-69866556 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs73826039 | chr4:69866562-69866563 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs112479985 | chr4:69866563-69866564 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs147387442 | chr4:69866579-69866580 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs550643044 | chr4:69866580-69866581 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs141732723 | chr4:69866618-69866619 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs539243088 | chr4:69866662-69866663 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs546529476 | chr4:69866695-69866696 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs566663593 | chr4:69866739-69866740 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs17147075 | chr4:69866745-69866746 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs535693032 | chr4:69866747-69866748 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs375839842 | chr4:69866753-69866754 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs555090388 | chr4:69866798-69866799 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs189923652 | chr4:69866822-69866823 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs537968211 | chr4:69866937-69866938 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs376790962 | chr4:69866958-69866959 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs557883752 | chr4:69866960-69866961 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs577555028 | chr4:69866972-69866973 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs150651366 | chr4:69866980-69866981 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs552377052 | chr4:69866998-69866999 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs368750164 | chr4:69866999-69867000 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs182091827 | chr4:69867030-69867031 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs114874718 | chr4:69867052-69867053 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs13104346 | chr4:69867066-69867067 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs13139536 | chr4:69867067-69867068 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs542472167 | chr4:69867076-69867077 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs561972670 | chr4:69867079-69867080 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs13104354 | chr4:69867083-69867084 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs185946818 | chr4:69867121-69867122 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs13149628 | chr4:69867132-69867133 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs13149630 | chr4:69867135-69867136 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs190748723 | chr4:69867138-69867139 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs139733193 | chr4:69867168-69867169 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs13104593 | chr4:69867178-69867179 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs546390512 | chr4:69867209-69867210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112521750 | chr4:69867229-69867230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367864712 | chr4:69867248-69867249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199926715 | chr4:69867260-69867261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201053362 | chr4:69867262-69867263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7670309 | chr4:69867264-69867265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10033842 | chr4:69867266-69867267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566630137 | chr4:69867297-69867298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs61469531 | chr4:69867299-69867300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372253479 | chr4:69867300-69867301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs57089454 | chr4:69867301-69867302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372283458 | chr4:69867331-69867332 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs60135097 | chr4:69867346-69867347 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69866000-69868000 | Weak transcription | Liver | Liver |
2 | chr4:69868000-69868400 | Strong transcription | Liver | Liver |
3 | chr4:69868000-69868800 | Enhancers | HepG2 | liver |
4 | chr4:69868400-69869200 | Weak transcription | Liver | Liver |